Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-12
2011-04-12
Anderson, James D (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S183000
Reexamination Certificate
active
07923447
ABSTRACT:
Disclosed herein are parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamide in N,N-dimethylactamide, polyethylene glycol and D5W useful in the treatment of hypertension, heart failure and renal disease leading to edematous states. Also disclosed are methods for preparing such solutions.
REFERENCES:
patent: 4668677 (1987-05-01), Morinaka et al.
patent: 5814623 (1998-09-01), Ranade
patent: 2006/0034926 (2006-02-01), Fraatz et al.
Ranade Vasant V.
Somberg John C.
Academic Pharmaceuticals Incorporated
Anderson James D
Finn Meghan
Vance Intellectual Property, PC
LandOfFree
Parenteral solutions containing metolazone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parenteral solutions containing metolazone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral solutions containing metolazone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696283